# Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida

> **NCT03961360** · PHASE2,PHASE3 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 220 (actual)

## Conditions studied

- Pre-Eclampsia
- Hypertension in Pregnancy
- Obesity

## Interventions

- **DRUG:** Aspirin 81 mg
- **DRUG:** Aspirin 162 mg

## Key facts

- **NCT ID:** NCT03961360
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-06
- **Primary completion:** 2023-04-10
- **Final completion:** 2023-04-10
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961360, "Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03961360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*